CN108623629B - 一类治疗血栓相关性疾病的化合物、制备方法及其药物用途 - Google Patents
一类治疗血栓相关性疾病的化合物、制备方法及其药物用途 Download PDFInfo
- Publication number
- CN108623629B CN108623629B CN201710162767.8A CN201710162767A CN108623629B CN 108623629 B CN108623629 B CN 108623629B CN 201710162767 A CN201710162767 A CN 201710162767A CN 108623629 B CN108623629 B CN 108623629B
- Authority
- CN
- China
- Prior art keywords
- compound
- pharmaceutical composition
- group
- composition according
- tablets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (11)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710162767.8A CN108623629B (zh) | 2017-03-18 | 2017-03-18 | 一类治疗血栓相关性疾病的化合物、制备方法及其药物用途 |
PCT/CN2017/082633 WO2018171004A1 (zh) | 2017-03-18 | 2017-04-28 | 一类治疗血栓相关性疾病的化合物、制备方法及其药物用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710162767.8A CN108623629B (zh) | 2017-03-18 | 2017-03-18 | 一类治疗血栓相关性疾病的化合物、制备方法及其药物用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108623629A CN108623629A (zh) | 2018-10-09 |
CN108623629B true CN108623629B (zh) | 2021-03-02 |
Family
ID=63584031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710162767.8A Active CN108623629B (zh) | 2017-03-18 | 2017-03-18 | 一类治疗血栓相关性疾病的化合物、制备方法及其药物用途 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN108623629B (zh) |
WO (1) | WO2018171004A1 (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105481861A (zh) * | 2014-09-19 | 2016-04-13 | 北京普禄德医药科技有限公司 | 一种血小板聚集抑制剂及其制备方法和用途 |
-
2017
- 2017-03-18 CN CN201710162767.8A patent/CN108623629B/zh active Active
- 2017-04-28 WO PCT/CN2017/082633 patent/WO2018171004A1/zh active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105481861A (zh) * | 2014-09-19 | 2016-04-13 | 北京普禄德医药科技有限公司 | 一种血小板聚集抑制剂及其制备方法和用途 |
Also Published As
Publication number | Publication date |
---|---|
WO2018171004A1 (zh) | 2018-09-27 |
CN108623629A (zh) | 2018-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6219016B2 (ja) | トレプロスチニル一水和物 | |
JP2007302658A (ja) | イマチニブメシレートの多形フォーム及び新規結晶フォーム及び非晶フォーム並びにフォームαの調製方法 | |
EP3048108B1 (en) | Thienopiperidine derivative and use thereof | |
EP3762386B1 (en) | Adenosine receptor antagonists and uses thereof | |
JP2005524715A (ja) | 新規2−(α−ヒドロキシペンチル)ベンゾエート、その調製およびその使用 | |
JP7264999B2 (ja) | 2-(1-アシルオキシ-n-ペンチル)安息香酸と塩基性アミノ酸またはアミノグアニジンによって形成される塩と、その製造方法及び用途 | |
RU2628800C2 (ru) | Амидные соединения, способы получения, применение в качестве средств для лечения и профилактики заболеваний, вызываемых рнк-содержащими вирусами | |
KR20020073589A (ko) | 축합 이미다졸륨 유도체 | |
WO2011140816A1 (zh) | 含腈基的噻吩并吡啶酯衍生物、其制备方法、应用和组合物 | |
WO2017050241A1 (zh) | 肌醇烟酸酯晶型a及其制备方法 | |
JPH05221980A (ja) | アセチレン化合物 | |
CN108623629B (zh) | 一类治疗血栓相关性疾病的化合物、制备方法及其药物用途 | |
WO2018209973A1 (zh) | 抗脑损伤氘代化合物及其医药用途 | |
CN102245606B (zh) | 新化合物 | |
WO2020062912A1 (zh) | 一种嘧啶磺酰胺类衍生物的医药用途 | |
JPS5919116B2 (ja) | 複素環式化合物の製造法 | |
CN102993210A (zh) | 一种吡啶并噻吩的新化合物 | |
JP5695797B2 (ja) | 新規抗血小板化合物の付加塩 | |
JP2018520128A (ja) | 重水素化チエノピペリジン誘導体、調製方法、及びその使用 | |
CN114588160A (zh) | 具有抗肺纤维化作用的次黄碱衍生物 | |
CA2990747C (en) | Phenyl amino pyrimidine compound or polymorph of salt thereof | |
TW201625543A (zh) | 羥吡啶酮衍生物,其醫藥組合物,及其用於發炎性、神經退化性或免疫媒介疾病之治療用途 | |
CN112047990B (zh) | 阿糖胞苷前药mb07133晶型及其应用 | |
CN102020574B (zh) | 丙泊酚γ-氨基丁酸酯的衍生物及其制备方法 | |
JPS63246378A (ja) | 8−アザキサンチン類、その製法及び医薬組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 230601 No.10 Wenshan Road, Hefei City, Anhui Province Patentee after: HEFEI INDUSTRIAL PHARMACEUTICAL INSTITUTE Co.,Ltd. Patentee after: HEFEI AMVITE PHARMACEUTICAL Co.,Ltd. Patentee after: NANJING MEDICAL INDUSTRY MEDICAL TECHNOLOGY Co.,Ltd. Address before: 230601 No.10 Wenshan Road, Hefei City, Anhui Province Patentee before: HEFEI YIGONG MEDICINE Co.,Ltd. Patentee before: HEFEI AMVITE PHARMACEUTICAL Co.,Ltd. Patentee before: NANJING MEDICAL INDUSTRY MEDICAL TECHNOLOGY Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A class of compounds, preparation methods and drug uses for the treatment of thrombus-related diseases Effective date of registration: 20230216 Granted publication date: 20210302 Pledgee: Jiujiang Bank Co.,Ltd. Anhui Pilot Free Trade Zone Hefei Area Sub branch Pledgor: HEFEI INDUSTRIAL PHARMACEUTICAL INSTITUTE Co.,Ltd.|HEFEI AMVITE PHARMACEUTICAL Co.,Ltd.|NANJING MEDICAL INDUSTRY MEDICAL TECHNOLOGY Co.,Ltd. Registration number: Y2023980032705 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |